International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 3 , Pages 825-830, 1 November 2007

Phase I Trial of Gross Total Resection, Permanent Iodine-125 Brachytherapy, and Hyperfractionated Radiotherapy for Newly Diagnosed Glioblastoma Multiforme

  • Allen M. Chen, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California, San Francisco School of Medicine, San Francisco, CA
  • ,
  • Susan Chang, M.D.

      Affiliations

    • Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, CA
  • ,
  • Jean Pouliot, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of California, San Francisco School of Medicine, San Francisco, CA
  • ,
  • Penny K. Sneed, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California, San Francisco School of Medicine, San Francisco, CA
  • ,
  • Michael D. Prados, M.D.

      Affiliations

    • Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, CA
  • ,
  • Kathleen R. Lamborn, Ph.D.

      Affiliations

    • Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, CA
  • ,
  • Mary K. Malec, B.S.

      Affiliations

    • Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, CA
  • ,
  • Michael W. McDermott, M.D.

      Affiliations

    • Department of Radiation Oncology, University of California, San Francisco School of Medicine, San Francisco, CA
    • Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, CA
  • ,
  • Mitchell S. Berger, M.D.

      Affiliations

    • Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, CA
  • ,
  • David A. Larson, Ph.D., M.D.

      Affiliations

    • Department of Radiation Oncology, University of California, San Francisco School of Medicine, San Francisco, CA
    • Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, CA
    • Corresponding Author InformationReprint requests to: David A. Larson, Ph.D., M.D., Department of Radiation Oncology, L-08, University of California, San Francisco School of Medicine, 505 Parnassus Ave., San Francisco, CA 94143-0226. Tel: (415) 353-8900; Fax (415) 353-8679

Received 6 December 2006; received in revised form 27 March 2007; accepted 28 March 2007. published online 17 May 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest: none.

PII: S0360-3016(07)00668-2

doi:10.1016/j.ijrobp.2007.03.061

International Journal of Radiation Oncology * Biology * Physics
Volume 69, Issue 3 , Pages 825-830, 1 November 2007